Lanean...
Comparing HMG‐CoA reductase inhibitors
The statins have proved to be some of the most potent therapies for reducing elevated low‐density lipoprotein (LDL) cholesterol and lessening the risk of coronary heart disease (CHD) and related events. Nonetheless, there are still questions about the clinical relevance of individual drug characteri...
Gorde:
| Argitaratua izan da: | Clin Cardiol |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Wiley Periodicals, Inc.
2007
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6653890/ https://ncbi.nlm.nih.gov/pubmed/12539818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960261306 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|